Le 17/05/2009 00:16, Charles Brault a écrit :

 

 

Volume 360:2079-2089   May 14, 2009
  Number 20

Epinephrine and Dexamethasone in Children with Bronchiolitis
Amy C. Plint, M.D., M.Sc., David W. Johnson, M.D., Hema Patel, M.D., M.Sc., Natasha Wiebe, M.Math., Rhonda Correll, H.B.Sc.N., Rollin Brant, Ph.D., Craig Mitton, Ph.D., Serge Gouin, M.D., Maala Bhatt, M.D., M.Sc., Gary Joubert, M.D., Karen J.L. Black, M.D., M.Sc., Troy Turner, M.D., Sandra Whitehouse, M.D., Terry P. Klassen, M.D., M.Sc., for Pediatric Emergency Research Canada (PERC)

ABSTRACT

 

 

Background Although numerous studies have explored the benefit of using nebulized epinephrine or corticosteroids alone to treat infants with bronchiolitis, the effectiveness of combining these medications is not well established.

Methods We conducted a multicenter, double-blind, placebo-controlled trial in which 800 infants (6 weeks to 12 months of age) with bronchiolitis who were seen in the pediatric emergency department were randomly assigned to one of four study groups. One group received two treatments of nebulized epinephrine (3 ml of epinephrine in a 1:1000 solution per treatment) and a total of six oral doses of dexamethasone (1.0 mg per kilogram of body weight in the emergency department and 0.6 mg per kilogram for an additional 5 days) (the epinephrine–dexamethasone group), the second group received nebulized epinephrine and oral placebo (the epinephrine group), the third received nebulized placebo and oral dexamethasone (the dexamethasone group), and the fourth received nebulized placebo and oral placebo (the placebo group). The primary outcome was hospital admission within 7 days after the day of enrollment (the initial visit to the emergency department).

Results Baseline clinical characteristics were similar among the four groups. By the seventh day, 34 infants (17.1%) in the epinephrine–dexamethasone group, 47 (23.7%) in the epinephrine group, 51 (25.6%) in the dexamethasone group, and 53 (26.4%) in the placebo group had been admitted to the hospital. In the unadjusted analysis, only the infants in the epinephrine–dexamethasone group were significantly less likely than those in the placebo group to be admitted by day 7 (relative risk, 0.65; 95% confidence interval, 0.45 to 0.95, P=0.02). However, with adjustment for multiple comparisons, this result was rendered insignificant (P=0.07). There were no serious adverse events.

Conclusions Among infants with bronchiolitis treated in the emergency department, combined therapy with dexamethasone and epinephrine may significantly reduce hospital admissions. (Current Controlled Trials number, ISRCTN56745572 [controlled-trials.com] .)


Source Information

The authors' affiliations are listed in the Appendix.

Address reprint requests to Dr. Plint at the Children's Hospital of Eastern Ontario, 401 Smyth Ave., Ottawa, ON K1H 8L1, Canada, or at [email protected] .

 

 

http://content.nejm.org/cgi/content/abstract/360/20/2079

 

 

quelqu'un qui comprend cet étrange langage peut il expliquer clairement comment on peut dire qu'après ajustement le resultat est "insignificant" (non signifiant ?) et dire 2 lignes plus tard que ça peut (may) diminuer significativement les hospitalisations


est ce ma compréhension de l'anglais (fort possible), du langage statistique (encore plus possible) ou alors ce sont les auteurs qui font des conclusions qui leur plaisent ?

merci

--
JF Pion
booster d'entropie
"If a cluttered desk is sign of a cluttered mind, of what, then, is an empty desk a sign ? " 
                                             Albert Einstein

Errare humanum est, perseverare politicum


"La différence entre l'homme politique et l'homme d'État est la suivante : le premier pense à la prochaine élection, le second à la prochaine génération".
James Freeman Clarke (1810-1888)



des montages électroniques pour le modélisme http://jean.francois.pion.free.fr
le site du vol électrique http://electrofly.free.fr/



Répondre à